Documente Academic
Documente Profesional
Documente Cultură
of the author and do not necessarily reflect the views or policies of the
Asian Development Bank (ADB), or its Board of Governors, or the
governments they represent. ADB does not guarantee the accuracy of the
data included in this paper and accepts no responsibility for any
consequence of their use. Terminology used may not necessarily be
consistent with ADB official terms.
Alia Luz
Health Intervention and Technology Assessment Programme of
Thailand
NHI4UHC
September 2016
Thailand
Thailand context:
3 insurance schemes
UHC in 2002
70% of total health spending is from the
government
HTA for the Universal Coverage Scheme (UCS)
of the government, which covers about 80% of
the Thai population
HTA = the systematic evaluation of properties,
effects, and/or impacts of health technology
UC BP development
Participatory-Transparent-Evidence-based-Contestable
7 groups of
stakeholders
Criteria:
Nomination of
interventions
a)
Stakeholders
Working Group
Researchers
Prioritization
Assessments
Cost-effectiveness
Budget impact
Committee for
Benefit
Package
Development
Appraisals
NHSO Board
Decisions
b)
Effectiveness of interventions
c)
Variation in practice
d)
Financial impact on
households
e)
problem of the
marginalized
Appeals by
stakeholders
rare diseases
Key Points
HTA helps in ensuring that resource allocations are
efficient
Results also assist in price negotiations with
pharmaceutical and medical companies
Conducting HTA for policy use is relatively low-cost
(approx. 0.002% of the UHC budget)
Countries around the region adopting HTA in some
form (e.g. Indonesia, Malaysia, Korea, etc.)
High proportion of investment, political
commitment, good information infrastructure, local
training, collaboration between agencies, and
independence from external support are factors
(APO Policy Brief)
Thank You!